Clinical Trial Update: Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on glibenclamide for aneurysmal subarachnoid hemorrhage; current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• Glibenclamide (glibenclamide)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Phase 4 | Status: UNKNOWN